STING1 and neoplasm: Antitumor effects of certain cGAMP derivatives and STING agonists (e.g., cyclic dinucleotides [CDNs]) have been reported in the mouse tumor models of skin, colon, breast, pancreatic, and B cell malignancies (Ng et al., 2018).